Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-01 5:00 pm Purchase |
2025-03-31 | 13G | NovoCure Limited NVCR |
Soleus Capital Master Fund, L.P. | 5,521,414 5.000% |
5,521,414 (New Position) |
Filing History |
| 2024-07-10 1:14 pm Purchase |
2024-06-28 | 13G | NovoCure Limited NVCR |
The Vanguard Group | 11,127,354 10.340% |
1,368,267 (+14.02%) |
Filing History |
| 2024-07-08 4:32 pm Purchase |
2024-06-30 | 13G | NovoCure Limited NVCR |
BLACKROCK INC BLK |
12,215,856 11.400% |
3,423,821 (+38.94%) |
Filing |
| 2024-02-13 5:09 pm Purchase |
2023-12-29 | 13G | NovoCure Limited NVCR |
The Vanguard Group | 9,759,087 9.130% |
211,751 (+2.22%) |
Filing History |
| 2024-02-09 6:14 pm Sale |
2024-02-07 | 13G | NovoCure Limited NVCR |
Capital World Investors | 3,276,996 3.100% |
-2,557,084 (-43.83%) |
Filing History |
| 2024-02-09 6:03 pm Purchase |
2024-02-07 | 13G | NovoCure Limited NVCR |
Capital International Investors | 8,896,076 8.300% |
740,167 (+9.08%) |
Filing History |
| 2024-02-09 11:32 am Purchase |
2023-12-31 | 13G | NovoCure Limited NVCR |
BLACKROCK INC BLK |
8,792,035 8.200% |
1,186,610 (+15.60%) |
Filing |
| 2024-02-09 09:28 am Purchase |
2024-02-08 | 13G | NovoCure Limited NVCR |
FMR CORP | 15,962,765 14.937% |
219,251 (+1.39%) |
Filing History |
| 2023-12-11 06:19 am Sale |
2023-12-11 | 13G | NovoCure Limited NVCR |
Capital World Investors | 5,834,080 5.500% |
-7,065,315 (-54.77%) |
Filing History |
| 2023-11-09 06:15 am Sale |
2023-10-31 | 13G | NovoCure Limited NVCR |
BAILLIE GIFFORD & CO | 5,095,777 4.770% |
-3,768,065 (-42.51%) |
Filing History |
| 2023-02-13 3:54 pm Sale |
2023-02-14 | 13G | NovoCure Limited NVCR |
Capital International Investors | 8,155,909 7.800% |
-3,375,166 (-29.27%) |
Filing History |
| 2023-02-13 2:49 pm Purchase |
2023-02-14 | 13G | NovoCure Limited NVCR |
Capital World Investors | 12,899,395 12.300% |
176,181 (+1.38%) |
Filing History |
| 2023-02-09 12:01 pm Purchase |
2023-02-09 | 13G | NovoCure Limited NVCR |
FMR CORP | 15,743,514 14.999% |
5,006,810 (+46.63%) |
Filing History |
| 2023-02-09 11:27 am Purchase |
2022-12-30 | 13G | NovoCure Limited NVCR |
The Vanguard Group | 9,547,336 9.100% |
1,654,023 (+20.95%) |
Filing History |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | NovoCure Limited NVCR |
BLACKROCK INC BLK |
7,605,425 7.200% |
916,069 (+13.69%) |
Filing |
| 2023-01-23 10:49 am Sale |
2022-12-30 | 13G | NovoCure Limited NVCR |
BAILLIE GIFFORD & CO | 8,863,842 8.450% |
-751,326 (-7.81%) |
Filing History |
| 2022-04-11 09:01 am Purchase |
2022-04-08 | 13G | NovoCure Limited NVCR |
FMR CORP | 10,736,704 10.281% |
2,926,367 (+37.47%) |
Filing History |
| 2022-02-11 2:48 pm Purchase |
2022-02-14 | 13G | NovoCure Limited NVCR |
Capital World Investors | 12,723,214 12.300% |
1,694,783 (+15.37%) |
Filing History |
| 2022-02-11 11:19 am Purchase |
2022-02-14 | 13G | NovoCure Limited NVCR |
Capital International Investors | 11,531,075 11.100% |
822,013 (+7.68%) |
Filing History |
| 2022-02-10 08:27 am Sale |
2021-12-31 | 13G | NovoCure Limited NVCR |
The Vanguard Group | 7,893,313 7.600% |
-350,657 (-4.25%) |
Filing History |